Skip to main content
Log in

Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Aim: To determine the incidence of coronary heart disease (CHD) in patients (pts) over 65 years (y) and its relation to common risk factors.Methods: We retrospectively studied 128 hemodialysis (HD) pts (80 M and 48 F), mean age 73 ± 6.5 years, mean time on HD 44.4 ± 26.4 months and BMI 25.4 ± 3 kg/m2. They were evaluated for: age, sex, smoking, diabetes, hypertension, left ventricular hypertrophy, secondary hyperparathyroidism (SHP), inflammation, as evidence by elevated level of hsCRP, hyperhomocysteinemia (HOC), time on HD, fluid overload and adequacy of HD. Forty-eight pts (37%) had CAD diagnosed by coronary angiography in 22 (46%) and 201TL-chloride dipyridamole stress test in 26 (54%).Results: There was a statistically significant correlation between CAD and increasing age (p < 0.0001). The relative risk was significantly increased concerning: (1) male over female pts (RR: 1.95, p < 0.01), (2) diabetic vs. non diabetic pts (RR: 2.09, p < 0.001), (3) patients with SHP over pts with iPTH values < 250 pg/ml (RR: 2.16, p < 0.001), (4) hypertensive vs. non hypertensive pts (RR: 2.26, p = 0.002), (5) smokers vs. non smokers (RR: 1.69, p < 0.05), (6) pts with HOC over pts with normal homocysteine values (RR: 2.09, p < 0.05), (7) pts with increased CRP levels over pts with normal CRP levels (RR: 1.8, p < 0.01), (8) pts undergoing HD for 36 vs. 12 months (RR: 1.71, p = 0.03), (9) between pts with inadequate or adequate HD (RR: 1.73, p = 0.02). No significant correlation existed between CAD incidence and the other risk factors.Conclusions: Coronary heart disease incidence in elderly HD patients increases with age, male sex, diabetes, SHP, hypertension, increased CRP levels, HOC, smoking, time on HD and inadequacy of HD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Trespalacios FC, Taylor AJ, Agodoa LY and Abbott KC (2002). Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62(5): 1799–1805

    Article  PubMed  Google Scholar 

  2. Murphy SW, Foley RN and Parfrey PS (1998). Screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 32: S184–S199

    PubMed  CAS  Google Scholar 

  3. Massy ZA (2000). Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 15: 81–91

    Article  PubMed  CAS  Google Scholar 

  4. Vaziri ND (2004). Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93–99

    Article  PubMed  CAS  Google Scholar 

  5. Shlipak MG, Fried LF and Cushman M (2005). Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293: 1737–1745

    Article  PubMed  CAS  Google Scholar 

  6. Parfrey PS (2000). Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant 15: 58–68

    Article  PubMed  Google Scholar 

  7. Meyer KB and Levey AS (1998). Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853–906

    PubMed  Google Scholar 

  8. Foley RN, Parfrey PS and Sarnak MJ (1998). Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112–S119

    PubMed  CAS  Google Scholar 

  9. Herzog CA, Ma JZ and Collins AJ (2002). Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106: 2207–2211

    Article  PubMed  Google Scholar 

  10. Rostand SG, Kirk KA and Rutsky EA (1984). Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 25: 653–659

    PubMed  CAS  Google Scholar 

  11. London GM and Parfrey PS (1997). Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 4: 194–211

    PubMed  CAS  Google Scholar 

  12. Cheung AK, Sarnak MJ and Yan G (2000). Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353–362

    Article  PubMed  CAS  Google Scholar 

  13. Longenecker JC, Coresh J and Powe NR (2002). Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 13: 1918–1927

    Article  PubMed  Google Scholar 

  14. Mallamaci F, Zoccali C and Tripepi G (2002). Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61: 609–614

    Article  PubMed  Google Scholar 

  15. United States Renal Data System Excerpts from the USRDS 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2005; 45(Suppl 1): S1.

  16. Psaty BM, Furberg CD and Kuller LH (1999). Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med 159: 1339

    Article  PubMed  CAS  Google Scholar 

  17. Newman AB (2001). Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 104(22): 2679–2684

    PubMed  CAS  Google Scholar 

  18. Seyrek N, Balal M and Karayaylali I (2003). Which parameter is more influential on the development of arteriosclerosis in hemodialysis patients?. Ren Fail 25: 1011–1018

    Article  PubMed  Google Scholar 

  19. Dahan M, Viron BM and Faraggi M (1998). Diagnostic accuracy and prognostic value of combined dipyridamole–exercise thallium imaging in hemodialysis patients. Kidney Int 54: 255–262

    Article  PubMed  CAS  Google Scholar 

  20. Volpato S, Guralnik J and Ferrucci L (2001). Cardiovascular disease, interleukin-6, and risk of mortality in older women : the women’s health and aging study. Circulation 103: 947–953

    PubMed  CAS  Google Scholar 

  21. Schimidt A, Stefenelli Th, Schnster E and Mayer G (2001). Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37: 56–63

    Google Scholar 

  22. US Preventative Services Task Force. Guide to Clinical Preventative Services, 2nd ed. Baltimore, MD: Williams and Williams, 1996

  23. Sugiura M, Hiraoka K and Ohkawa S (1976). Severity of coronary sclerosis in the aged: a pathological study in 968 consecutive autopsy cases. Jpn Heart J 17: 471

    PubMed  CAS  Google Scholar 

  24. Rabbat CG, Treleaven DJ and Russell JD (2003). Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney–pancreas transplantation: a meta-analysis. J Am Soc Nephrol 14: 431–439

    Article  PubMed  Google Scholar 

  25. Beattie JN, Soman SS and Sandberg KR (2001). Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191–1200

    Article  PubMed  CAS  Google Scholar 

  26. Hase H, Jokin N and Ishikawa H (2004). Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 19(5): 1161–1167

    Article  PubMed  Google Scholar 

  27. Best PJ, Lennon R and Ting HH (2002). The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39: 1113–1119

    Article  PubMed  Google Scholar 

  28. Kronenberg F, Neyer U and Lhotta K (1999). The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol 10: 1027–1036

    PubMed  CAS  Google Scholar 

  29. Sarnak MJ, Levey AS and Schoolwerth AC (2003). Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154–2169

    Article  PubMed  Google Scholar 

  30. Himmelfarb J, Stenvinkel P, Ikizler TA and Hakim RM (2002). The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524–1438

    Article  PubMed  CAS  Google Scholar 

  31. Xia H, Ebben J, Ma JZ and Collins AJ (1999). Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 10: 1309–1316

    PubMed  CAS  Google Scholar 

  32. Boaz M, Smetana S and Weinstein T (2000). Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo-controlled trial. Lancet 356: 1213–1218

    Article  PubMed  CAS  Google Scholar 

  33. Vaziri ND, Dicus M and Ho ND (2003). Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179–185

    Article  PubMed  CAS  Google Scholar 

  34. Santoro A and Mancini E (2002). Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant 17: 10–15

    Article  PubMed  Google Scholar 

  35. Kasiske BL, Ramos EL and Gaston RS (1995). The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 6: 3431–3439

    Google Scholar 

  36. Longenecker JC, Klag MJ and Marcovina SM (2002). Small apolipoprotein (a) size predicts mortality in end-stage renal disease: The CHOICE study. Circulation 106: 2812–2818

    Article  PubMed  CAS  Google Scholar 

  37. Muntner P, He J and Hamm L (2002). Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745

    PubMed  Google Scholar 

  38. Longenecker JC, Coresh J and Powe NR (2002). Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 13: 1918

    Article  PubMed  Google Scholar 

  39. Landray MJ, Thambyrajah J and McGlynn FJ (2001). Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38: 537

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theodore C. Chiras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soubassi, L.P., Chiras, T.C., Papadakis, E.D. et al. Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis. Int Urol Nephrol 38, 795–800 (2006). https://doi.org/10.1007/s11255-006-0039-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-0039-9

Keywords

Navigation